Abstract
Incomplete Financial Disclosure: In the Original Contribution entitled “Relapse of Major Depression During Pregnancy in Women Who Maintain or Discontinue Antidepressant Treatment” published in the February 1, 2006, issue of JAMA (2006;295:499-507), financial disclosures were omitted. The complete disclosure statement follows: Dr Altshuler is a consultant to Abbott Laboratories, Eli Lilly, Forest Pharmaceuticals, Janssen Pharmaceutica, Pfizer, Solvay, and Bristol-Myers Squibb; receives grant support from Abbott, Eli Lilly, Forest, GlaxoSmithKline, and Solvay; has received honoraria from Abbott, Bristol-Myers Squibb, Eli Lilly, Forest, and GlaxoSmithKline; and is on the speakers bureaus and/or advisory boards of Abbott, Astra Zeneca, Bristol-Myers Squibb, Eli Lilly, Forest, GlaxoSmithKline, Pfizer, Wyeth, and Solvay. Dr Burt is a consultant for Eli Lilly, GlaxoSmithKline, Bristol-Myers Squibb, and AstraZeneca, and has received honoraria from and is on the speakers and/or advisory boards for Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, AstraZeneca, Forest, and Pfizer. Dr Cohen has received grant support from AstraZeneca Pharmaceuticals, Berlex Laboratories, Eli Lilly, Forest, GlaxoSmithKline, Janssen Pharmaceuticals, Sepracor, and Wyeth-Ayerst; is a consultant for Eli Lilly, GlaxoSmithKline, Janssen, Ortho-McNeil Pharmaceuticals, Novartis Pharmaceuticals, and Wyeth-Ayerst; and is on the speakers bureau of AstraZeneca, Berlex, Eli Lilly, Forest, GlaxoSmithKline, Janssen, Pfizer, and Wyeth-Ayerst. Dr Hendrick is a member of the speakers bureaus for GlaxoSmithKline, Forest, and Pfizer. Dr Newport has served on the speakers bureaus for GlaxoSmithKline, Lilly, and Pfizer. Dr Nonacs is on the speakers bureau of GlaxoSmithKline. Dr Stowe has served on the speakers bureaus for GlaxoSmithKline, Wyeth, and Pfizer; has received grants from GlaxoSmithKline and Wyeth; and has served on advisory boards for Bristol-Myers Squibb and GlaxoSmithKline. Dr Suri has received an honorarium for a speaking engagement with Pfizer. Dr Viguera is on the speakers bureau of GlaxoSmithKline.
Journal
JAMA
– American Medical Association
Published: Jul 12, 2006